How a Marine Veteran Avoided Repeat Spinal Fusion After Years of Chronic Pain with Biologic Disc Repair
Patient Overview
Sgt. Mark Jensen, a 46-year-old retired Marine Corps veteran, presented to ValorSpine with a complex history of chronic lower back pain. Mark’s service career spanned 22 years, during which he experienced multiple deployments, heavy lifting, and the concussive forces associated with blast exposure in combat zones. These demanding conditions took a toll on his spine, leading to early onset degenerative disc disease. He was medically retired due to his deteriorating spinal health, a decision that deeply affected his ability to maintain an active lifestyle and engage fully with his family. Despite his stoic resolve forged in service, the relentless pain had eroded his quality of life, making even simple tasks like walking his dog or sitting through a meal an arduous challenge. He arrived at ValorSpine seeking a definitive solution, hoping to avoid further invasive surgeries that had previously yielded only temporary relief and new complications.
The Challenge
Mark’s primary complaint was severe, persistent low back pain, rated consistently at 7-8 out of 10 on a daily basis. This pain radiated into his right buttock and thigh, often causing a sensation of weakness and instability. His medical history was significant: five years prior, he underwent an L5-S1 spinal fusion to address a severely degenerated disc and associated instability, a condition directly linked to his military service. While the initial recovery provided a period of relative relief, new symptoms began to emerge within two years post-fusion. Diagnostic imaging, including MRI, revealed classic signs of adjacent segment disease (ASD) at the L4-L5 level, immediately above his fused segment. This phenomenon, where discs adjacent to a fusion endure increased biomechanical stress, had led to accelerated degeneration and annular tears at L4-L5, and also showed signs of developing issues at L3-L4. Furthermore, his MRI indicated persistent discogenic pain originating from the damaged L4-L5 disc, characterized by high-intensity zones (HIZ) on T2-weighted images, indicative of active annular tears.
The pain was significantly exacerbated by prolonged sitting, standing, and any form of physical exertion. Mark found it impossible to sit for more than 15-20 minutes without experiencing sharp, escalating pain. This limitation profoundly impacted his daily life, preventing him from driving for extended periods, attending his children’s school events, or even enjoying a movie. He had been forced to abandon hobbies he once cherished, such as fishing and light hiking, and the constant discomfort contributed to sleep disturbances and a growing sense of frustration and isolation. His biggest fear was facing another, potentially more extensive, spinal fusion, as he had witnessed firsthand the prolonged recovery and potential for new problems associated with such major interventions. He yearned for a solution that would not only alleviate his pain but also restore his function without the need for additional hardware or sacrificing more spinal motion segments.
Previous Treatments Tried
Before finding ValorSpine, Mark had explored a wide array of conservative and interventional treatments over several years, initially for his L5-S1 degeneration and later for the emergent adjacent segment disease. His journey began with extensive physical therapy programs, focusing on core strengthening, flexibility, and proper body mechanics. Despite diligent adherence to these regimens, the relief was always transient and never addressed the underlying structural integrity of his discs. Chiropractic care offered temporary adjustments but no lasting impact on his chronic pain.
Pharmacological interventions included various non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and short courses of stronger opioid pain medications during severe flare-ups. While these provided symptomatic relief, they did not resolve the root cause and carried the risk of long-term side effects and dependency. Over a period of three years, Mark received no fewer than seven epidural steroid injections, targeting both the lumbar spine and caudal epidural space. Each injection provided a window of pain reduction, typically lasting a few weeks to a couple of months, but the pain invariably returned to its baseline severity, confirming that the inflammation was merely being masked, not healed.
He also underwent a trial of radiofrequency ablation (RFA) at one point, hoping to denervate the facet joints, but his pain was primarily discogenic, and the RFA offered no discernible benefit. After the diagnosis of adjacent segment disease at L4-L5, his previous surgeon had recommended a second fusion, extending from L4 to L5, and potentially even to L3. This prospect was deeply unsettling for Mark. He understood the implications of fusing more segments – reduced spinal mobility, extended recovery, and the heightened risk of further adjacent segment degeneration. It was at this critical juncture, feeling desperate and disheartened by the conventional options, that Mark began researching alternative, less invasive treatments for disc repair, ultimately leading him to ValorSpine and the promise of biologic disc repair.
Our Approach
At ValorSpine, our approach to patients like Mark is rooted in a comprehensive understanding of spinal biomechanics, regenerative medicine, and a commitment to preserving natural spinal function whenever possible. Upon his initial consultation, we conducted a thorough review of Mark’s extensive medical history, imaging studies (including his pre- and post-fusion MRIs, and a recent lumbar MRI), and a detailed physical examination. We recognized that his adjacent segment disease and persistent discogenic pain at L4-L5, with evidence of annular tears, made him an ideal candidate for a biologic, minimally invasive treatment.
Our philosophy centers on addressing the structural integrity of the disc itself, rather than merely managing symptoms. For Mark, this meant targeting the damaged annulus of his L4-L5 disc, where tears were allowing the internal disc material to leak, causing inflammation and pain. Unlike fusion, which eliminates motion, or discectomy, which removes disc material and can lead to instability, our strategy focuses on encouraging the body’s natural healing capabilities. We proposed an intra-annular fibrin injection procedure, a cutting-edge biologic disc repair treatment designed to seal the annular tears and restore the structural integrity of the disc. This approach aims to prevent further leakage of disc material, reduce inflammation, and create an optimal environment for the disc to stabilize and potentially regenerate its internal structure.
We spent considerable time discussing the procedure with Mark, explaining how the fibrin acts as a scaffold to close the tears, and outlining the expected recovery timeline, which is significantly less demanding than a repeat fusion. We also emphasized that while this treatment offered a powerful solution, it requires patient commitment to a post-procedure rehabilitation protocol to maximize healing and ensure long-term success. Our goal was not just pain reduction, but a restoration of functional capacity that would allow Mark to reclaim the active life he once enjoyed, free from the shadow of repeat major surgery.
Treatment Process
Following a thorough evaluation and shared decision-making, Mark elected to proceed with the intra-annular fibrin injection for his L4-L5 disc. The procedure itself is performed on an outpatient basis and is minimally invasive, typically requiring only local anesthesia and mild sedation to ensure patient comfort. Under advanced fluoroscopic (real-time X-ray) guidance, a very fine needle was precisely guided into the damaged L4-L5 disc. The precision of this guidance is critical to ensure accurate delivery of the fibrin without affecting surrounding neural structures.
Once the needle was correctly positioned within the annular tear, the fibrin biopolymer was carefully injected. This medical-grade fibrin solution, derived from human blood products, acts as a biological sealant and scaffold. Upon injection, it polymerizes, forming a durable, flexible seal over the annular tears. This seal effectively closes the fissures in the disc’s outer wall, preventing further leakage of the nucleus pulposus (the jelly-like inner disc material) and stopping the inflammatory cascade that contributes to discogenic pain. The fibrin also provides a structural matrix that encourages the body’s own fibroblasts to migrate into the area, promoting long-term healing and potentially strengthening the disc wall over time.
The entire procedure typically takes less than an hour. Immediately following the injection, Mark was moved to a recovery area for a short observation period. He was given clear post-procedure instructions, which included a period of reduced activity to allow the fibrin to fully integrate and the initial healing process to begin. This typically involved avoiding heavy lifting, twisting, and prolonged sitting for the first few weeks, gradually reintroducing light activity as tolerated. A tailored physical therapy program was prescribed to commence a few weeks post-procedure, focusing initially on gentle core stabilization and mobility exercises, progressing to strengthening as his healing progressed. Mark’s commitment to these post-procedure guidelines was paramount for the success of the biologic repair.
The Results
Mark’s recovery journey, while requiring patience, yielded significant and life-changing improvements. In the immediate days following the procedure, he experienced some mild, expected post-injection soreness, which resolved quickly. Within 3-4 weeks, he reported a noticeable reduction in the intensity and frequency of his low back pain. The sharp, radiating pain into his right buttock and thigh began to subside, and the constant ache that had plagued him for years started to diminish. By the 2-month mark, Mark’s pain scores had dropped from a consistent 7-8/10 to an average of 3-4/10. He was able to sit for longer periods, up to 45 minutes, without needing to frequently shift or stand up.
At his 4-month follow-up, the improvements were even more dramatic. His pain was consistently in the 2-3/10 range, a moderate to significant improvement of approximately 60-70%. Crucially, the radicular symptoms in his leg had almost entirely resolved. He reported a substantial increase in his functional capacity. He was regularly walking his dog for longer distances, driving without significant discomfort, and had even started light hiking again. The fear of another fusion surgery had lifted, replaced by a renewed sense of hope and optimism. By the 6-month mark, Mark was actively participating in a modified exercise routine, including swimming and bodyweight exercises. He was able to attend his son’s baseball games, sitting through the entire duration, something that was unimaginable just months prior.
At the one-year mark, Mark’s pain remained stable at a low level, and he reported a return to nearly all his pre-injury activities, albeit with continued awareness of proper body mechanics. He attributed his success not only to the biologic disc repair but also to the comprehensive post-procedure guidance and his own dedication to the rehabilitation process. His case illustrates the profound potential of intra-annular fibrin injection as a viable and effective alternative for patients with discogenic pain and annular tears, especially those facing the daunting prospect of repeat spinal surgery or adjacent segment disease.
Key Takeaways
Sgt. Mark Jensen’s case underscores several critical points about chronic discogenic pain and the transformative potential of advanced biologic treatments. Firstly, for patients suffering from adjacent segment disease following previous spinal fusions, or those with significant annular tears leading to discogenic pain, traditional options often lead to more invasive surgeries. However, intra-annular fibrin injection offers a powerful, minimally invasive alternative that focuses on preserving spinal mobility and promoting the body’s natural healing processes.
Secondly, the success of this biologic disc repair highlights the importance of accurate diagnosis and targeting the root cause of pain – in Mark’s case, the damaged L4-L5 annulus. By sealing the tears and stabilizing the disc, the procedure not only alleviates pain but also helps prevent further degeneration and potentially avoids the cascading effects of adjacent segment disease. This patient’s journey is a testament to the fact that even after years of chronic pain and failed conventional treatments, including a previous fusion, significant pain relief and functional restoration are achievable.
Finally, Mark’s story reinforces ValorSpine’s commitment to patient-centered care, offering cutting-edge solutions that prioritize long-term well-being and improved quality of life. For veterans like Mark, whose spines have endured immense stress, these innovative treatments provide a pathway to regaining independence and an active lifestyle without the drawbacks of repeated major surgical interventions. This case study demonstrates that for many, avoiding another spinal fusion is not just a hope, but a tangible reality through advanced biologic disc repair.
“After years of fighting this pain, and facing another fusion, ValorSpine gave me my life back. I can finally sit through a meal with my family, enjoy a walk, and not constantly dread the next flare-up. It’s truly a game-changer.”
— Sgt. Mark Jensen, Retired Marine Corps Veteran
If you would like to read more, we recommend this article: How a Marine Veteran Avoided Repeat Spinal Fusion After Years of Chronic Pain with Biologic Disc Repair
